Adjunctive treatment with aripiprazole for olanzapine-induced hyperprolactinemia

INTRODUCTION: Hyperprolactinemia is a common unwanted antipsychotic-induced adverse effect, particularly in female patients, and can induce poor adherence to treatment. Aripiprazole is an antipsychotic with partial agonist activity over the dopamine D2 receptors which can be effective in reducing hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bise, S., Sulejmanpasic, G., Hrnjica, A., Šarkić-Bedak, Š.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567633/
http://dx.doi.org/10.1192/j.eurpsy.2022.2003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567633/
http://dx.doi.org/10.1192/j.eurpsy.2022.2003

Ejemplares similares